메뉴 건너뛰기
New England Journal of Medicine
Volumn 372, Issue 17, 2015, Pages 1670-1671
Ruxolitinib versus standard therapy for the treatment of polycythemia vera
Author keywords

[No Author keywords available]
Indexed keywords

HYDROXYUREA; RECOMBINANT ALPHA2 INTERFERON; RUXOLITINIB; INTERFERON; ANTINEOPLASTIC AGENT; JANUS KINASE; PYRAZOLE DERIVATIVE;
EID: 84928476375     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1502524     Document Type: Letter
Times cited : (121)
References (5)
  • 1
    • 84921891315 scopus 로고    scopus 로고
    • Ruxolitinib versus standard therapy for the treatment of polycythemia vera
    • Vannucchi AM, Kiladjian JJ, Griesshammer M, et al. Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med 2015;372:426-35.
    • (2015) N Engl J Med , vol.372 , pp. 426-435
    • Vannucchi, A.M.1    Kiladjian, J.J.2    Griesshammer, M.3
  • 2
    • 79551491928 scopus 로고    scopus 로고
    • Philadelphia-negative classical myeloproliferative neoplasms: Critical concepts and management recommendations from European LeukemiaNet
    • Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol 2011;29:761-70.
    • (2011) J Clin Oncol , vol.29 , pp. 761-770
    • Barbui, T.1    Barosi, G.2    Birgegard, G.3
  • 3
    • 84865229049 scopus 로고    scopus 로고
    • Correlation of blood counts with vascular complications in essential thrombocythemia: Analysis of the prospective PT1 cohort
    • Campbell PJ, MacLean C, Beer PA, et al. Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort. Blood 2012;120:1409-11.
    • (2012) Blood , vol.120 , pp. 1409-1411
    • Campbell, P.J.1    MacLean, C.2    Beer, P.A.3
  • 4
    • 84883742082 scopus 로고    scopus 로고
    • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study
    • Tefferi A, Rumi E, Finazzi G, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 2013;27:1874-81.
    • (2013) Leukemia , vol.27 , pp. 1874-1881
    • Tefferi, A.1    Rumi, E.2    Finazzi, G.3
  • 5
    • 84873368311 scopus 로고    scopus 로고
    • Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    • Silver RT, Kiladjian JJ, Hasselbalch HC. Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis. Expert Rev Hematol 2013;6:49-58.
    • (2013) Expert Rev Hematol , vol.6 , pp. 49-58
    • Silver, R.T.1    Kiladjian, J.J.2    Hasselbalch, H.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.